Balyasny Asset Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-54,953
| Closed | -$275K | – | 1962 |
|
|
2025
Q1 | $275K | Sell |
54,953
-141,374
| -72% | -$707K | ﹤0.01% | 1736 |
|
|
2024
Q4 | $1.42M | Buy |
196,327
+16,387
| +9% | +$118K | ﹤0.01% | 1184 |
|
|
2024
Q3 | $1.1M | Buy |
+179,940
| New | +$1.1M | ﹤0.01% | 1299 |
|
|
2023
Q4 | – | Sell |
-947,578
| Closed | -$2.46M | – | 1887 |
|
|
2023
Q3 | $2.46M | Buy |
947,578
+248,051
| +35% | +$645K | 0.01% | 952 |
|
|
2023
Q2 | $2.47M | Buy |
699,527
+208,839
| +43% | +$737K | 0.01% | 969 |
|
|
2023
Q1 | $2.07M | Buy |
490,688
+310,940
| +173% | +$1.31M | 0.01% | 1098 |
|
|
2022
Q4 | $2.96M | Sell |
179,748
-857,914
| -83% | -$14.1M | 0.01% | 921 |
|
|
2022
Q3 | $13.3M | Buy |
1,037,662
+831,193
| +403% | +$10.6M | 0.04% | 468 |
|
|
2022
Q2 | $2.42M | Buy |
+206,469
| New | +$2.42M | 0.01% | 1064 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 1078 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 961 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 412 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 371 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 411 |
|